Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl) acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles

Archiv der Pharmazie

Volumn 338, Issue 2-3, 2005, Pages 105-111

  Temiz Arpaci, Özlem ^a   Özdemir, Aliye ^a   Yalçin, Ismail ^a   Yildiz, Ilkay ^a   Aki Şener, Esin ^a   Altanlar, Nurten ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antibacterial activity; Antifungal activity; Benzoxazoles; Morpholine aceteamide; Piperazine acetamide

Indexed keywords

ACETAMIDE DERIVATIVE; BENZOXAZOLE DERIVATIVE; CHLORIDE; CHLOROACETYL CHLORIDE; CIPROFLOXACIN; GENTAMICIN; HALOPROGIN; MICONAZOLE; MORPHOLINE; MORPHOLINE ACETAMIDE; MORPHOLINE DERIVATIVE; OXICONAZOLE; PIPERAZINE ACETAMIDE; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; DILUTION; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BENZOXAZOLES; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 17844374872     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200400923     Document Type: Article

References (36)

1. R. Norrby, Exp. Opin. Pharmacother. 2001, 2, 293-302.
2. A. N. Tomasz, Engl. J. Med. 1994, 330, 1247-1251.
3. T. Hisano, M. Ichikawa, K. Tsumoto, M. Tasaki, Chem. Pharm. Bull. 1982, 30, 2996-3004.
4. M. Prudhomme, J. Guyot, G. Jeminet, J. Antibiotics 1986, 39 934-937.
5. S. Ersan, S. Nacak, R. Berkem, T. Özden, Arzneim. Forsch. 1997, 47, 963-965.
6. H. M. El-Shaaer, S. A. Abdel-Aziz, H. A. Allimony, R. M. Abdel-Rahman, Pharmazie 1997, 52, 585-589.
7. M. A. Weidner-Wells, K. A. Ohemeng, V. N. Nguyen, S. Fraga-Spano, M.J. Macielag, H. M. Werblood, B. D. Foleno, G. C. Webb, J. F. Barrett, D. J. Hlasta, Bioorg. Med. Chem. Lett. 2001, 11, 1545-1548.
8. E. Şener, İ. Yalçin, E. Sungur, Quant. Struc. Act. Relat. 1991, 10, 223-228.
9. E. Şener, İ. Yalçin, Ö. Temiz, İ. Ören, A. Akin, N. Uçartürk, Farmaco 1996, 52, 99-103.
10. İ. Ören, Ö. Temiz, Ï. Yalçin, E. Şener, A. Akin, N. Uçartürk, Arzneim. Forsch. 1991, 47, 1393-1397.
11. Ö. Temiz, İ. Ören, E. Şener, İ. Yalçin, N. Uçartürk, Farmaco 1998, 53, 337-341.
12. İ. Yalçin, İ. Ören, E. Şener, A. Akin, N. Uçartürk, Eur. J. Med. Chem. 1992, 27, 401-406.
13. J. Kogi, V. Klimegova, K. Waisser, J. Kaustava, H. M. Dahse, U. Möllmann, Bioorg. Med. Chem. Letters, 2002, 12, 3275-3278.
14. M. Ueki, K. Ueno, S. Miyadoh, K. Abe, K. Shibata, M. Taniguchi, J. Antibiotics 1993, 46, 1089-1094.
15. D. F. Shi, T. D. Bradshaw, S. Wrigley, C. J. McCall, P. Lelieveld, I. Fichtner, M. F. G. Stevens, J. Med. Chem. 1996, 39, 3375-3384.
16. M. DeLuca, S. Kerwin, Tetrahedron Letters 1997, 38, 199-202.
17. M. B. Reynolds, M. DeLuca, S. Kerwin, Bioorg. Chem. 1999, 27, 326-337.
18. Z. M. Nofal, M. El-Zahar, S. S. Abd El-Karim, Molecules 2000, 5, 99-153.
19. S. Sato, T. Kajiura, M. Noguchi, K. Takehana, T. Kobayashi, T. Tsuji, J. Antibiotics 2001, 54, 102-104.
20. W. S. Saari, J. S. Wai, T. E. Fisher, C. M. Thomas, J. M. Hoffman, C. S. Roomey, A. M. Smith, J. H. Jones, D. L. Bamberger, M. E. Goldman, J. A. O'Brien, J. H. Nunberg, J. C. Quintero, Q. A. Schleif, E. A. Emini, P. S. Anderson, J. Med. Chem. 1992, 35, 3792-3802.
21. M. E. Goldman, J. A. O'Brien, T. L. Ruffing, W. A. Schleif, V. V. Sardana, V. W. Byrnes, J. H.Condra, J. M. Hoffman, E. A. Emini, Antimicrob. Agents Chemother. 1993, 37, 947-949.
22. J. M. Hoffman, A. M. Smith, C. S. Rooney, T. E. Fisher, J. S. Wai, C. M. Thomas, D. L. Bambmerger, J. L. Barnes, T. M. Williams, J. H. Jones, B. D. Olson, J. A. O'Brien, M. E. Goldmah, J. H. Nunberg, J. C. Quintero, W. A. Schleif, E. A. Emini, P. S. Anderson, J. Med. Chem. 1993, 36, 953-966.
23. R. T. Davey, R. L. Dewar, G. F. Reed, M. B. Vasudevachari, M. A. Polis, J. A. Kovacs, J. Falloon, R. E. Walker, H. Masur, S. E. Haneiwich, D. G. O'Neil, M. R. Decker, J. A. Metcalf, M. A. Deloria, O. L. Laskin, N. Salzman, H. C. Lone, Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 5608-5612.
24. S. Staszewski, F. E. Massari, A. Kober, R. Göhler, S. Durr, K. W. Anderson, C. L. Schneider, J. A. Waterburry, K. K. Bakshi, V. I. Taylor, J. Infect Dis. 1995, 171, 1159-1165.
25. D. B. Olsen, S. S. Carroll, J. C. Culberson, J. A. Shafer, L. C. Kuo, Nucleic Acids Res. 1994, 22, 1437-1443.
26. W. Dolbier, C. Burkholder, M. Medebielle, J. Fluor. Chem. 1999, 95, 127-130.
27. J. S. Kim, Q. Sun, B. Gatto, C. Yu, A. Liu, L. F. Liu, E. J. La Voie, Bioorg. Med. Chem. 1996, 4, 621-630.
28. M. Peel, M. Milstead, D. Sternbach, J. Besterman, P. Leitner, B. Morton, M. Wall, M. Wani, Bioorg. Med. Chem. Lett. 1995, 5, 2129-2131.
29. D. Kumar, M. R. Jacob, M. B. Reynolds, S. M. Kerwin, Bioorg. Med. Chem., 2002, 10, 3997-4004.
30. D. D. Martin, N. R. Kotecha, S. V. Ley, S. Maqntegani, J. C. Menendes, H. M. Organ, A. D. White, Tetrahedron 1992, 48, 7899-7938.
31. E. A. Sener, Ö. T. Arpaci, İ. Yalcin, N. Altanlar, N., Il Farmaco 2000, 55, 397-405.
32. Ö. T. Arpai, E. A. Sener, İ. Yalçin, N. Altanlar, Arch. Pharm. Pharm. Med. Chem. 2002, 335, 283-288.
33. İ. Yalçin, B. K. Kaymakcioǧlu, İ. Ören, E. Şener, Ö. Temiz, A. Akin, N. Altanlar, Il Farmaco 1997, 52, 685-689.
34. L. E. Totton, C. L. Raiford, J. Am. Chem. Soc. 1954, 76, 5127-5130.
35. E. S. Charles, V. K. Agrawal, S. Sharma, R. N. Iyer, Eur. J. Med. Chem., Chim. Ther. 1979, 4, 435-438.
36. S. Shadomy, A. Espinel in Manual of clinical microbiology (Ed.: E. H. Lenette), Am. Soc. Microbiol, Washington, DC, 1980, pp. 647.